Cargando…

Therapeutic Efficacy of a Novel Acetylated Tetrapeptide in Animal Models of Age-Related Macular Degeneration

It has been shown previously that a novel tetrapeptide, Arg-Leu-Tyr-Glu (RLYE), derived from human plasminogen inhibits vascular endothelial growth factor (VEGF)-induced angiogenesis, suppresses choroidal neovascularization in mice by an inhibition of VEGF receptor-2 (VEGFR-2) specific signaling pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koo, Hye Cheong, Baek, Yi-Yong, Choi, Jun-Sup, Kim, Young-Myeong, Sung, Bokyung, Kim, Min-Jung, Kim, Jae Gyu, You, Ji Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070582/ https://www.ncbi.nlm.nih.gov/pubmed/33918777 http://dx.doi.org/10.3390/ijms22083893

Ejemplares similares

Topical Administration of a Novel Acetylated Tetrapeptide Suppresses Vascular Permeability and Immune Responses and Alleviates Atopic Dermatitis in a Murine Model
por: Sung, Bokyung, et al.
Publicado: (2022)

Milk Protein-Derived Antioxidant Tetrapeptides as Potential Hypopigmenting Agents
por: Kong, Saerom, et al.
Publicado: (2020)

Arg-Leu-Tyr-Glu tetrapeptide inhibits tumor progression by suppressing angiogenesis and vascular permeability via VEGF receptor-2 antagonism
por: Baek, Yi-Yong, et al.
Publicado: (2016)

Directed Discovery of Tetrapeptide Emulsifiers
por: Scott, Gary G., et al.
Publicado: (2022)

Complement System and Potential Therapeutics in Age-Related Macular Degeneration
por: Park, Young Gun, et al.
Publicado: (2021)

Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide – AcSDKP
por: Boutonnat, Jean, et al.
Publicado: (2005)

Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration
por: Kim, Kyoungmi, et al.
Publicado: (2017)

Anti-tumour effect of the physiological tetrapeptide, tuftsin.
por: Nishioka, K.
Publicado: (1979)

Fibronectin tetrapeptide is target for syphilis spirochete cytadherence
Publicado: (1985)

Increase in the Population of Patients with Neovascular Age-Related Macular Degeneration Who Underwent Long-Term Active Treatment
por: Baek, Seung Kook, et al.
Publicado: (2019)

Therapeutic Approaches for Age-Related Macular Degeneration
por: Galindo-Camacho, Ruth M., et al.
Publicado: (2022)

Enantioselective Sulfonylation Reactions Mediated by a Tetrapeptide Catalyst
por: Fiori, Kristin Williams, et al.
Publicado: (2009)

Author Correction: Increase in the Population of Patients with Neovascular Age-Related Macular Degeneration Who Underwent Long-Term Active Treatment
por: Baek, Seung Kook, et al.
Publicado: (2020)

Depression and anxiety in age-related macular degeneration
por: Kim, Eung Suk, et al.
Publicado: (2016)

Monthly Alternating Injections of Aflibercept and Bevacizumab for Neovascular Age-Related Macular Degeneration
por: Lee, Junyeop, et al.
Publicado: (2022)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Studying Age-Related Macular Degeneration Using Animal Models
por: Fletcher, Erica L., et al.
Publicado: (2014)

In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal Models
por: Baek, Yi-Yong, et al.
Publicado: (2021)

Antifungal Activity of Cyclic Tetrapeptide from Bacillus velezensis CE 100 against Plant Pathogen Colletotrichum gloeosporioides
por: Choub, Vantha, et al.
Publicado: (2021)

CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
por: Koo, Taeyoung, et al.
Publicado: (2018)

Exploring the Energy Landscapes of Cyclic Tetrapeptides with Discrete Path Sampling
por: Oakley, Mark T., et al.
Publicado: (2012)

Twists or turns: stabilising alpha vs. beta turns in tetrapeptides
por: Hoang, Huy N., et al.
Publicado: (2019)

Histidine-based copper tetrapeptides as enantioselective catalysts for aldol reactions
por: Sharifa Zaithun, Begum, et al.
Publicado: (2018)

Structure-activity relationships of mitochondria-targeted tetrapeptide pharmacological compounds
por: Mitchell, Wayne, et al.
Publicado: (2022)

Therapeutic Modalities of Exudative Age-related Macular Degeneration
por: Mavija, Milka, et al.
Publicado: (2014)

High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration
por: Lee, Dong Kyu, et al.
Publicado: (2016)

The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-related Macular Degeneration
por: Shin, Kyung-Hoon, et al.
Publicado: (2016)

Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment
por: Moon, Bo-Hyun, et al.
Publicado: (2023)

Automated Segmentation Methods of Drusen to Diagnose Age-Related Macular Degeneration Screening in Retinal Images
por: Kim, Young Jae, et al.
Publicado: (2018)

Nutlin-3a for age-related macular degeneration
por: Chung, Hyewon, et al.
Publicado: (2022)

Molecular Mechanisms of Retinal Pigment Epithelium Dysfunction in Age-Related Macular Degeneration
por: Kim, Jongmin, et al.
Publicado: (2021)

Spectroscopic and Theoretical Studies of Hg(II) Complexation with Some Dicysteinyl Tetrapeptides
por: Springfield, Elliot, et al.
Publicado: (2021)

Prion-derived tetrapeptide stabilizes thermolabile insulin via conformational trapping
por: Mukherjee, Meghomukta, et al.
Publicado: (2021)

Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegeneration
por: Nhu, Nguyen Thanh, et al.
Publicado: (2022)

Zn-dependent β-amyloid Aggregation and its Reversal by the Tetrapeptide HAEE
por: Mitkevich, Vladimir A, et al.
Publicado: (2023)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
por: Nashine, Sonali
Publicado: (2021)

Genetic Aspects of Age-Related Macular Degeneration and Their Therapeutic Potential
por: Stradiotto, Elisa, et al.
Publicado: (2022)

Age-Related Macular Degeneration: Advances in Management and Diagnosis
por: Yonekawa, Yoshihiro, et al.
Publicado: (2015)

Macrophages and Macular Degeneration
por: Jager, Martine J.
Publicado: (2014)

Brolucizumab for macular degeneration
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t8e3i2dc7nubs51smbq8r6jofa